Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
PELP1: A novel therapeutic target for hormonal cancers Chakravarty D; Tekmal RR; Vadlamudi RKIUBMB Life 2010[Mar]; 62 (3): 162-9Recent studies implicate that the estrogen receptor (ER) coregulator proline-, glutamic acid-, and leucine-rich protein (PELP) 1 as playing critical roles in ER-genomic, ER-nongenomic, and ER-signaling cross talk with growth factor signaling pathways. PELP1 expression is deregulated in hormonal cancers and recent studies further elucidated the molecular mechanisms by which PELP1 regulates hormone therapy response. Although PELP1 is important for normal functions of the ER, the possibility to target ER-PELP1 axis appears to be an effective strategy for preventing hormonal carcinogenesis and therapy resistance. Thus, PELP1 may be useful as prognostic marker for hormonal cancers and PELP1 signaling may be useful to generate targeted therapeutics to overcome hormonal therapy resistance.|Antineoplastic Agents, Hormonal/*therapeutic use[MESH]|Breast Neoplasms/*drug therapy[MESH]|Co-Repressor Proteins[MESH]|Drug Resistance, Neoplasm/genetics[MESH]|Female[MESH]|Humans[MESH]|Neoplasm Metastasis/physiopathology[MESH]|Neoplasms, Hormone-Dependent/*drug therapy[MESH]|Receptors, Estrogen/*drug effects/physiology[MESH]|Signal Transduction/physiology[MESH]|Trans-Activators/drug effects/*physiology[MESH]|Transcription Factors[MESH] |
